News
DoKaSch Temperature Solutions expands its business in India
The Indian pharmaceutical industry worldwide ranks third in pharmaceutical production by volume, according to the Indian government. In order to position itself even better in this region, DoKaSch Temperature Solutions has announced James Savio as Business Development Manager India. “I...
Drug Research
Sever Pharma Solutions breaks ground with new high potency drug manufacturing suites
Sever Pharma Solutions, a leading pharmaceutical contract development and manufacturing organization (CDMO), has announced the groundbreaking of its new high potency active pharmaceutical ingredients (HPAPI) manufacturing suites. The company’s investment in these new state-of-the-art manufacturing facilities will allow them...
Drug Research
Bora merges with Sunway Biotech to launch global Nutraceuticals offering
Bora Health, a global design, development and distribution partner of pharmaceuticals and health foods and part of the Bora group, has announced its merged with Sunway Biotech, a leading ingredients manufacturer, and research and development (R&D) organization. Resulting in...
News
Mural Health Raises $8M Led by Bessemer Venture Partners to Accelerate Growth
Mural Health Technologies, Inc. a next-generation clinical trial participant management platform announced that it has raised $8 million in seed funding, led by Bessemer Venture Partners, with participation from Virtue VC, Operator Partners, Arkitect Ventures, Correlation Ventures, and Project...
Drug Research
Accelerating Drug Development Through CDMO Partnerships
Based on current market analyses, global pharmaceutical spending is projected to reach approximately $1,742 billion by 2025. Concurrently, spending on COVID-19 vaccines and therapeutics is anticipated to reach around $53 billion worldwide in the same year.
Two predominant trends currently...
News
Prefilled Syringes Market Surges To $18.43 Billion In 2023
The global market for prefilled syringes reached a value of USD 18.43 billion in 2023 and is expected to experience a compound annual growth rate (CAGR) of 11.95% from 2023 to 2030. This growth is primarily fueled by the...
News
Takeda Reiterates the Need of Equitable Access to Healthcare for Universal Impact
Takeda Biopharmaceuticals India Private Limited (formerly Baxalta Bioscience India Pvt Ltd) – a global values-based, R&D-driven biopharmaceutical leader in innovative healthcare solutions presented an industry perspective on equitable access to healthcare during the 5th edition of the Confederation of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















